TD Waterhouse Canada’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-190
Closed -$3.63K – 1800
2023
Q4
$3.63K Sell
190
-23
-11% -$463 ﹤0.01% 1426
2023
Q3
$5.73K Sell
213
-20
-9% -$491 ﹤0.01% 1336
2023
Q2
$5.92K Hold
233
– – ﹤0.01% 1346
2023
Q1
$6.38K Hold
233
– – ﹤0.01% 1317
2022
Q4
$5.22K Hold
233
– – ﹤0.01% 1340
2022
Q3
$4.05K Hold
233
– – ﹤0.01% 1391
2022
Q2
$5.25K Sell
233
-12
-5% -$319 ﹤0.01% 1384
2022
Q1
$8.95K Sell
245
-313
-56% -$8.78K ﹤0.01% 1355
2021
Q4
$16.5K Buy
+558
New +$14.6K ﹤0.01% 1243

Other funds holding CLB

TD Waterhouse Canada's CLB Position: Q1 2024 in Review

TD Waterhouse Canada sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 190 shares — an estimated $3.63K sold.

TD Waterhouse Canada first reported a position in CLB in Q4 2021 and held it in 9 quarters. The position peaked at $16.5K in Q4 2021. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • TD Waterhouse Canada reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 190 Core Laboratories shares in Q1 2024, an estimated $3.63K.
  • TD Waterhouse Canada first reported a position in Core Laboratories in Q4 2021 and held it in 9 quarters.
  • TD Waterhouse Canada's Core Laboratories position peaked at $16.5K in Q4 2021.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on TD Waterhouse Canada's 13F filing for Q1 2024, filed 10 May 2024.